Validity of gracevit in patients with febrile neutropenia.

Validity of gracevit in patients with febrile neutropenia. - Validity of gracevit

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015354

Enrollment

Registered

2014-10-06

Start date

2014-10-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

febrile neutropenia

Interventions

gracevit

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with low grade febrile neutropenia (patient has 21-26 points in MASCC score )

Exclusion criteria

Exclusion criteria: a past history of the side effect of a gracevit younger than age-lower limit

Design outcomes

Primary

Measure	Time frame
fever period	—

Countries

Japan

Contacts

Public ContactMineyuki Hama

shinshu university first department of internal medicine

mineyuki@shinshu-u.ac.jp0263-37-2631

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026